INTUS BIOSCIENCES, LLC

Profile

Company Names

INTUS BIOSCIENCES, LLC
SHORELINE BIOME, LLC

Addresses

400 FARMINGTON AVENUE, FARMINGTON, CT 06032

400 FARMINGTON AVENUE, CB 119, FARMINGTON, CT 06032

Phone Numbers

917-859-6568
203-619-4083

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2014

State Incorporated:

CONNECTICUT

Total Amount Raised:

$10,116,492.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-05-15 
$1,089,996.00 
$3,000,000.00 
$1,910,004.00 
Equity 
9
2024-06-25 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity, Debt 
8
2022-11-07 
$1,050,003.00 
$3,490,477.00 
$2,440,474.00 
Equity 
7
2022-06-27 
$800,000.00 
$1,500,000.00 
$700,000.00 
Debt 
6
2022-01-22 
$250,000.00 
$250,000.00 
$0.00 
Debt 
5
2020-12-23 
$330,000.00 
$1,000,000.00 
$670,000.00 
Debt 
4
2019-05-23 
$2,214,434.00 
$2,214,434.00 
$0.00 
Equity 
3
2017-12-15 
$1,842,059.00 
$1,917,059.00 
$75,000.00 
Debt 
2
2016-05-13 
$500,000.00 
$500,000.00 
$0.00 
Equity, Debt 
1
2016-01-07 
$40,000.00 
$500,000.00 
$460,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
DENSLOW 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
DRISCOLL 
DIRECTOR
MARK 
D. 
DRISCOLL 
EXECUTIVE OFFICER, DIRECTOR
DONNA 
 
GALLUZZO 
DIRECTOR
THOMAS 
 
JARVIE 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
JARVIE 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
P. 
JARVIE 
EXECUTIVE OFFICER, DIRECTOR
H. MARK 
 
LUNENBURG 
DIRECTOR
FRANK 
 
MARCO 
DIRECTOR
FRANK 
J. 
MARCO 
DIRECTOR
WILLIAM 
 
MCKENZIE 
DIRECTOR
MATT 
 
WATSON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-06-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-06-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-01-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-12-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-15 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-05-13 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-01-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#